PharmaTher Holdings Ltd (TSE:PHRM)
CNQX:PHRM
Holding TSE:PHRM?
Track your performance easily

PharmaTher Holdings Ltd (PHRM) Stock Price & Analysis

10 Followers

PHRM Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

17.51%<0.01%82.49%
17.51% Insiders
<0.01% Other Institutional Investors
82.49% Public Companies and
Individual Investors

PHRM FAQ

What was PharmaTher Holdings Ltd’s price range in the past 12 months?
PharmaTher Holdings Ltd lowest stock price was C$0.11 and its highest was C$0.43 in the past 12 months.
    What is PharmaTher Holdings Ltd’s market cap?
    Currently, no data Available
    When is PharmaTher Holdings Ltd’s upcoming earnings report date?
    PharmaTher Holdings Ltd’s upcoming earnings report date is Jan 24, 2025 which is in 71 days.
      How were PharmaTher Holdings Ltd’s earnings last quarter?
      Currently, no data Available
      Is PharmaTher Holdings Ltd overvalued?
      According to Wall Street analysts PharmaTher Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does PharmaTher Holdings Ltd pay dividends?
        PharmaTher Holdings Ltd pays a Notavailable dividend of C$0.03 which represents an annual dividend yield of N/A. See more information on PharmaTher Holdings Ltd dividends here
          What is PharmaTher Holdings Ltd’s EPS estimate?
          PharmaTher Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does PharmaTher Holdings Ltd have?
          PharmaTher Holdings Ltd has 88,519,066 shares outstanding.
            What happened to PharmaTher Holdings Ltd’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of PharmaTher Holdings Ltd?
            Currently, no hedge funds are holding shares in TSE:PHRM
            ---

            PharmaTher Holdings Ltd Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            47.61%
            12-Months-Change

            Fundamentals

            Return on Equity
            -71.01%
            Trailing 12-Months
            Asset Growth
            -54.76%
            Trailing 12-Months

            Company Description

            PharmaTher Holdings Ltd

            Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation, is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals. Pharmather repurposes psychedelic pharmaceuticals, such as ketamine and psilocybin, for FDA approval to treat disorders of the brain and nervous system.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            PharmaTher Holdings Ltd
            Relmada Therapeutics
            Bristol-Myers Squibb
            Gilead Sciences
            Johnson & Johnson
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis